HAM
ABMD

Highstreet Asset Management’s Abiomed Inc ABMD Stock Holding History

Highstreet Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,562
Closed -$667K – 463
2019
Q2 		$667K Buy
2,562
+719
+39% +$191K 0.03% 192
2019
Q1 		$526K Sell
1,843
-131
-7% -$43.5K 0.03% 211
2018
Q4 		$642K Buy
+1,974
New +$686K 0.04% 197

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Highstreet Asset Management's ABMD Position: Q3 2019 in Review

Highstreet Asset Management sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 2,562 shares — an estimated $667K sold.

Highstreet Asset Management first reported a position in ABMD in Q4 2018 and held it in 3 quarters. The position peaked at $667K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Highstreet Asset Management reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Highstreet Asset Management sold 2,562 Abiomed Inc shares in Q3 2019, an estimated $667K.
  • Highstreet Asset Management first reported a position in Abiomed Inc in Q4 2018 and held it in 3 quarters.
  • Highstreet Asset Management's Abiomed Inc position peaked at $667K in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Highstreet Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.